Author:
Campbell-Baird Cynthia,Harrelson Stacey,Frey Georgette,Balakumaran Arun
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Lipton A, Goessl C (2011) Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis. Bone 48(1):96–99. doi: 10.1016/j.bone.2010.10.161
2. Yu HH, Tsai YY, Hoffe SE (2012) Overview of diagnosis and management of metastatic disease to bone. Cancer Control 19(2):84–91
3. Xie J, Namjoshi M, Wu EQ, Parikh K, Diener M, Yu AP, Guo A, Culver KW (2011) Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases. J Manag Care Pharm 17(8):621–643
4. Coleman R (2007) Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer. Clin Breast Cancer 7(Suppl 1):S29–S35
5. Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(8 Suppl):1588–1594. doi: 10.1002/(SICI)1097-0142(19971015)80
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献